86 related articles for article (PubMed ID: 15958323)
1. [Relationship between serum vWF and PAF in type 2 diabetic patients and diabetic nephropathy].
Fang YH; Zhang JP; Zhou SX; Zheng JF; Yu YW; Yan SG; Fan WK; Cheng YS
Di Yi Jun Yi Da Xue Xue Bao; 2005 Jun; 25(6):729-31. PubMed ID: 15958323
[TBL] [Abstract][Full Text] [Related]
2. [Clinical analysis of serum endothelin in type 2 diabetic patients with vascular complications].
Fang YH; Zhang JP; Zhou SX; Zheng JF; Yu YW; Yan SG; Fan WK; Chen YS
Di Yi Jun Yi Da Xue Xue Bao; 2005 Aug; 25(8):1007-8, 1011. PubMed ID: 16109562
[TBL] [Abstract][Full Text] [Related]
3. Relations between von Willebrand factor, markers of oxidative stress and microalbuminuria in patients with type 2 diabetes mellitus.
Ibrahim HA; El-Meligi AA; Abdel-Hamid M; Elhendy A
Med Sci Monit; 2004 Mar; 10(3):CR85-9. PubMed ID: 14976459
[TBL] [Abstract][Full Text] [Related]
4. Endothelial dysfunction, ambulatory pulse pressure and albuminuria are associated in Type 2 diabetic subjects.
Knudsen ST; Jeppesen P; Frederiksen CA; Andersen NH; Bek T; Ingerslev J; Mogensen CE; Poulsen PL
Diabet Med; 2007 Aug; 24(8):911-5. PubMed ID: 17559428
[TBL] [Abstract][Full Text] [Related]
5. Hemorheology, plasma protein composition and von Willebrand factor in type I diabetic nephropathy.
Zimmermann J; Schramm L; Wanner C; Mulzer E; Henrich HA; Langer R; Heidbreder E
Clin Nephrol; 1996 Oct; 46(4):230-6. PubMed ID: 8905207
[TBL] [Abstract][Full Text] [Related]
6. Heterogeneous nature of microalbuminuria in NIDDM: studies of endothelial function and renal structure.
Fioretto P; Stehouwer CD; Mauer M; Chiesura-Corona M; Brocco E; Carraro A; Bortoloso E; van Hinsbergh VW; Crepaldi G; Nosadini R
Diabetologia; 1998 Feb; 41(2):233-6. PubMed ID: 9498659
[TBL] [Abstract][Full Text] [Related]
7. von Willebrand factor (vWf) as a plasma marker of endothelial activation in diabetes: improved reliability with parallel determination of the vWf propeptide (vWf:AgII).
Vischer UM; Emeis JJ; Bilo HJ; Stehouwer CD; Thomsen C; Rasmussen O; Hermansen K; Wollheim CB; Ingerslev J
Thromb Haemost; 1998 Dec; 80(6):1002-7. PubMed ID: 9869174
[TBL] [Abstract][Full Text] [Related]
8. Von Willebrand factor in type 1 diabetes: its production and coronary artery calcification.
Chan NN; Fuller JH; Rubens M; Colhoun HM
Med Sci Monit; 2003 Jul; 9(7):CR297-303. PubMed ID: 12883448
[TBL] [Abstract][Full Text] [Related]
9. Influence of renal involvement on peripheral blood mononuclear cell expression behaviour of tumour necrosis factor-alpha and interleukin-6 in type 2 diabetic patients.
Navarro JF; Mora C; Gómez M; Muros M; López-Aguilar C; García J
Nephrol Dial Transplant; 2008 Mar; 23(3):919-26. PubMed ID: 17911088
[TBL] [Abstract][Full Text] [Related]
10. The relationship between adrenomedullin, metabolic factors, and vascular function in individuals with type 2 diabetes.
Lim SC; Morgenthaler NG; Subramaniam T; Wu YS; Goh SK; Sum CF
Diabetes Care; 2007 Jun; 30(6):1513-9. PubMed ID: 17384335
[TBL] [Abstract][Full Text] [Related]
11. Endothelial dysfunction and oxidative stress in type 1 and type 2 diabetic patients without clinical macrovascular complications.
De Mattia G; Bravi MC; Laurenti O; Moretti A; Cipriani R; Gatti A; Mandosi E; Morano S
Diabetes Res Clin Pract; 2008 Feb; 79(2):337-42. PubMed ID: 17949845
[TBL] [Abstract][Full Text] [Related]
12. Impaired flow-mediated vasodilatation and insulin resistance in type 2 diabetic patients with albuminuria.
Makino H; Doi K; Hiuge A; Nagumo A; Okada S; Miyamoto Y; Suzuki M; Yoshimasa Y
Diabetes Res Clin Pract; 2008 Jan; 79(1):177-82. PubMed ID: 17904244
[TBL] [Abstract][Full Text] [Related]
13. Elevated serum C-reactive protein level and microalbuminuria in patients with type 2 diabetes mellitus.
Mojahedi MJ; Bonakdaran S; Hami M; Sheikhian MR; Shakeri MT; Aiatollahi H
Iran J Kidney Dis; 2009 Jan; 3(1):12-6. PubMed ID: 19377253
[TBL] [Abstract][Full Text] [Related]
14. Familial factors in diabetic nephropathy: an offspring study.
Agius E; Attard G; Shakespeare L; Clark P; Vidya MA; Hattersley AT; Fava S
Diabet Med; 2006 Mar; 23(3):331-4. PubMed ID: 16492220
[TBL] [Abstract][Full Text] [Related]
15. Association of haptoglobin phenotypes with markers of diabetic nephropathy in Type 2 diabetes mellitus.
Awadallah SM; Saleh SA; Abu Shaqra QM; Hilow H
J Diabetes Complications; 2008; 22(6):384-8. PubMed ID: 18413152
[TBL] [Abstract][Full Text] [Related]
16. Impact of the Thr789Ala variant of the von Willebrand factor levels, on ristocetin co-factor and collagen binding capacity and its association with coronary heart disease in patients with diabetes mellitus type 2.
Klemm T; Mehnert AK; Siegemund A; Wiesner TD; Gelbrich G; Blüher M; Paschke R
Exp Clin Endocrinol Diabetes; 2005 Dec; 113(10):568-72. PubMed ID: 16320153
[TBL] [Abstract][Full Text] [Related]
17. Combined therapy of rhein and benazepril on the treatment of diabetic nephropathy in db/db mice.
Jia ZH; Liu ZH; Zheng JM; Zeng CH; Li LS
Exp Clin Endocrinol Diabetes; 2007 Oct; 115(9):571-6. PubMed ID: 17943690
[TBL] [Abstract][Full Text] [Related]
18. Neutrophil surface expression of CD11b and CD62L in diabetic microangiopathy.
Mastej K; Adamiec R
Acta Diabetol; 2008 Sep; 45(3):183-90. PubMed ID: 18496641
[TBL] [Abstract][Full Text] [Related]
19. Relationship between total oxidant status and severity of diabetic nephropathy in type 2 diabetic patients.
Aslan M; Sabuncu T; Kocyigit A; Celik H; Selek S
Nutr Metab Cardiovasc Dis; 2007 Dec; 17(10):734-40. PubMed ID: 17321120
[TBL] [Abstract][Full Text] [Related]
20. [Changes in serum and urine ceruloplasmin concentrations in type 2 diabetes].
Qin LX; Zeng X; Huang G
Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2004 Apr; 29(2):208-11. PubMed ID: 16145917
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]